Evaluation of fluorescence hs-CRP immunoassay for point-of-care testing

Clinica Chimica Acta

Volumn 356, Issue 1-2, 2005, Pages 172-177

  Sang, Wook Oh ^a   Jung, Dae Moon ^a   Sang, Yeol Park ^a   Heuk, Jae Jang ^b   Jae, Hoon Kim ^c   Ki, Bong Nahm ^d   Eui, Yul Choi ^a,d  

^a BodiTech Med Inc   (South Korea)

^b Seoul National University   (South Korea)

^c Hanyang University   (South Korea)

^d Hallym University   (South Korea)

Author keywords

Anti CRP mAb; Cardiovascular diseases; hs CRP; Immunoassay; POCT

Indexed keywords

BUFFER; C REACTIVE PROTEIN;

ADULT; AGED; ANALYTIC METHOD; APPARATUS; ARTICLE; ASSAY; BLOOD; CHROMATOGRAPHY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; EVALUATION; FEMALE; FLUORESCENCE; HEMOCONCENTRATION; HUMAN; IMMUNOASSAY; INCUBATION TIME; INTERMETHOD COMPARISON; LASER; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NEPHELOMETRY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; SAMPLE; STATISTICAL ANALYSIS; TURBIDIMETRY;

ADULT; AGED; AGED, 80 AND OVER; ARTERIOSCLEROSIS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHROMATOGRAPHY; FEMALE; FLUORESCENCE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; POINT-OF-CARE SYSTEMS;

EID: 20344402528     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2005.01.026     Document Type: Article

References (15)

1. M.B. Pepys, and G.M. Hirschfield C-reactive protein: a critical update J Clin Invest 111 2003 1805 1812
2. J.E. Volanakis Human C-reactive protein: expression, structure, and function Mol Immunol 38 2001 189 197
3. M.O. Pentikanen, K. Oorni, M. Ala-Korpela, and P.T. Kovanen Modified LDL-trigger of atherosclerosis and inflammation in the arterial intima J Intern Med 247 2000 359 370
4. P.M. Ridker, M. Cushman, M.J. Stampfer, R.P. Tracy, and C.H. Hennekens Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979
5. W. Koenig, M. Sund, and M. Frohlich C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men Circulation 99 1999 237 242
6. L.M. Biasucci, G. Liuzzo, and R.L. Grillo Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability Circulation 99 1999 855 860
7. N. Rifai, and P.M. Ridker Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening Clin Chem 47 2001 28 30
8. G. Taubes Does inflammation cut to the heart of the matter? Science 296 2002 242 245
9. J. Wilkins, J.R. Gallimore, E.G. Moore, and M.B. Pepys Rapid automated high sensitivity enzyme immunoassay of C-reactive protein Clin Chem 44 1998 1358 1361
10. P.M. Ridker, N. Rifai, and M.A. Pfeffer For the cholesterol and recurrent events (CARE) investigators. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels Circulation 98 1998 839 844
11. J.S. Ahn, S. Choi, S.H. Jang, H.J. Jang, J.H. Kim, and K.B. Nahm Development of a point-of-care-assay system for high-sensitivity C-reactive protein in whole blood Clin Chim Acta 332 1-2 2003 51 56
12. W.L. Roberts, L. Moulton, T.C. Law, G. Farrow, J. Savory, and N. Rifai Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological application: Part 2 Clin Chem 47 2001 418 425
13. P. Tarkkinen, T. Palenius, and T. Lovgren Ultrarapid, ultrasensitive one-step kinetic immunoassay for C-reactive protein (cRP) in whole blood samples: measurement of the entire cRP concentration range with a single sample dilution Clin Chem 48 2002 269 277
14. D.E. Brooks, D.V. Devine, and P.C. Harris RAMP(TM): a rapid, quantitative whole blood immunochromatographic platform for point-of-care testing Clin Chem 45 1999 1676 1678
15. Anders Larsson, and Lars-Olof Hansson Evaluation of a modified hsCRP method for point-of service testing Clin Chim Acta 334 1-2 2003 249 252